The structural pharmacokinetic model for paclitaxel, accounting with the Cremophor EL™ affect, was a three-compartment product using a nonlinear product for paclitaxel plasma clearance (CL), involving a linear lower Within this parameter during the infusion and also a sigmoidal raise with time after the infusion.Use or redistribution of any DrugB